Method for producing composition for removing harmful substance and method for removing harmful substance
A nanobubble-based composition inactivates viruses and microorganisms by generating high-energy bursts from collapsing nanosized bubbles, addressing the inefficacies and health risks of existing methods, providing effective and safe decontamination.
Patent Information
- Application Number
- JP2024153548
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2020-03-27
- Filing Date
- 2024-09-06
- Publication Date
- 2024-11-28
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
Existing methods for removing harmful substances such as viruses and microorganisms are either ineffective due to resistance development or pose health risks, and nanobubble technologies primarily focus on sterilization rather than targeted substance removal.
A composition containing nanosized bubbles generated by a rotary shearing method, without ozone, utilizing gases like atmosphere, hydrogen, nitrogen, oxygen, carbon dioxide, or argon, to collapse and inactivate viruses and microorganisms through high-energy release.
The composition effectively removes viruses and microorganisms by collapsing nanobubbles to generate high-energy bursts, achieving decontamination without using harmful substances and inhibiting growth, thus avoiding resistance and health risks.
Smart Images

Figure 2024166262000002 
Figure 2024166262000001
Abstract
Description
[Technical field]
[0001] The present invention relates to a method for efficiently producing a composition for removing harmful substances such as viruses and / or microorganisms, and a method for removing harmful substances. [Background technology]
[0002] As seen in the annual influenza epidemics, viruses have the ability to mutate and acquire countermeasures against antiviral drugs and antibodies, making the battle between humanity and viruses a never-ending game of cat and mouse.
[0003] On the other hand, viruses are sensitive to heat, and it is said that they can be inactivated by denaturing the outer shell protein called capsid protein (or coat protein) at 56℃ for 30 minutes. However, some viruses are very heat-resistant, such as non-enveloped viruses that do not have a lipid membrane (envelope) around the capsid protein, so this level of heating is not sufficient, and there are also places where it is impossible to maintain a temperature and time sufficient for inactivation using an external heat source, so there are limitations to decontamination by artificial heating.
[0004] Conventionally, methods of sterilization and virus removal using ozone water have been developed, but because large amounts of ozone are harmful to the human body, it has been necessary to exercise caution when using this method.
[0005] The use of nanobubble water for this ozone sterilization has also been considered (Non-Patent Document 1), but this mainly utilizes the antibacterial power of ozone itself, and aims to improve the long-term storage stability of ozone and deliver ozone to small locations by utilizing nanobubbles that are partially generated by the collapse of microbubbles, but does not remove viruses, etc. by the collapse of the nanobubbles themselves.
[0006] Meanwhile, progress has been made in the development of devices that generate nanobubbles with diameters of less than 1 μm, and solutions containing these bubbles (nanobubble water) have come to be used in various fields, such as medicine, agriculture, and fisheries and aquaculture. For example, nanobubble water is known to be used in the fisheries industry for sterilization, but the effectiveness of this has not been sufficient.
[0007] The present inventors have developed a technology that utilizes a solution containing a group of bubbles with an average bubble diameter of nano-sized or less (less than 1 μm) (hereinafter, may be referred to as "nanobubble water") for intestinal flora transplantation, etc. (Patent Document 1). However, this is a technology that uses bubbles to protect intestinal bacteria, etc., and allows them to attach alive to the intestine, and is rather the opposite of technologies for removing harmful substances, etc., including sterilization. [Prior art documents] [Patent documents]
[0008] [Patent Document 1] WO2019 / 168034 [Non-patent literature]
[0009] [Non-Patent Document 1] Fundamentals and Engineering Applications of Microbubbles and Nanobubbles - Examination of New Possibilities of Ozone - (Masayoshi Takahashi, Bulletin of the Japanese Society for Medical and Environmental Ozone Research, Vol. 14, No. 4, 68-74. (2007)) Summary of the Invention [Problem to be solved by the invention]
[0010] The present inventors came up with the idea of applying the energy generated when phenomena such as the collapse of fine bubbles present in nanobubble water occur to virus decontamination, sterilization, and the like. Furthermore, in our intestinal flora transplantation technology described in Patent Document 1, the high "storage stability" of the intestinal bacteria for transplantation was demonstrated by the "maintenance of proliferation activity" of the intestinal bacteria treated with nanobubble water (Test Example 6). However, after noticing that the proliferation rate itself was slower than the intrinsic proliferation rate of the intestinal bacteria, the inventors suspected that nanobubbles may also have an effect of suppressing the proliferation rate of bacteria, and arrived at the present invention, the object of which is to provide a method for producing a composition that can effectively remove harmful substances such as viruses and microorganisms. [Means for solving the problem]
[0011] The above object can be achieved by the following first to sixth inventions.
[0012] <First invention> A method for producing a composition for removing harmful substances, which does not contain a bactericidal component, characterized in that the composition contains the following (I) and (II), wherein the harmful substance is at least one selected from viruses, microorganisms, and toxins.
[0013] (I) A group of bubbles having an average bubble diameter of nano-sized or less (less than 1 μm) (excluding those containing ozone as a gas component in the bubbles), which is obtained by a bubble generating step of generating bubbles by a rotational shear method, and a nanobubble generating step of converting the bubbles generated by the bubble generating step into nanobubbles using a filter. (II) Solvent
[0014] <Second Invention> The method for producing the composition according to the first aspect of the present invention, wherein the gas component in the bubbles is one or more of the following:
[0015] (i) Atmosphere (ii) Hydrogen (iii) Nitrogen (iv) Oxygen (v) Carbon dioxide (vi) Argon
[0016] <Third Invention> A method for producing the composition according to the first or second invention, characterized in that the concentration of (I) is 50 million / ml or more.
[0017] <The fourth invention> A method for producing a composition according to any one of the first to third aspects of the present invention, characterized in that the concentration of (I) is 80 million / ml or more.
[0018] <Fifth Invention> A method for producing a composition according to any one of the first to fourth aspects of the present invention, characterized in that the harmful substance is at least one selected from viruses and / or microorganisms.
[0019] <The sixth invention> A method for removing harmful substances using a composition according to any one of the first to fifth aspects of the present invention. Effect of the Invention
[0020] The "composition for removing harmful substances" of the present invention can effectively remove viruses, microorganisms, and other harmful substances simply by dissipating energy through the collapse of bubbles, etc., without using as its main ingredient chemicals that may cause resistance, or substances such as ozone, which have high disinfecting power but are harmful to the human body. [Brief description of the drawings]
[0021] [Figure 1] FIG. 1 shows the results of measuring the size, number, etc. of bubbles in the “harmful substance removing composition (nanobubble water)” (4000-fold diluted solution for measurement) of Examples 1 to 3 used in the present invention. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0022] The present invention will be described in detail below.
[0023] [Composition for removing harmful substances according to the present invention] The "composition for removing hazardous substances" of the present invention is characterized by comprising the following (I) and (II). (I) A group of bubbles with an average bubble diameter of nano-sized or less (less than 1 μm) (II) Solvent
[0024] Harmful substances refer to viruses, microorganisms, toxins, radioactive materials, and any other substances that have adverse effects on the human body. However, it is preferable that the substances be substances that can be removed by the energy generated by the collapse of bubbles (heat equivalent to 2,300°C).
[0025] (What is a virus?) The "viruses" to be "removed" by the composition of the present invention include all known and unknown (such as new and unidentified) viruses that have harmful effects on the human body. Examples of structural classification include: single- or double-stranded DNA viruses, Single- or double-stranded RNA viruses, A hybrid consisting of single-stranded DNA and single-stranded RNA. A chimera in which RNA and DNA are combined to form a single strand The following are some of the reasons: Among them, pathogenic viruses are preferred because the application of the present invention is effective, but the application is not limited to these.
[0026] Furthermore, the term "virus" includes not only naturally occurring viruses, but also "modified forms" of viruses that have been artificially manipulated, those synthesized from scratch, or parts of viruses (modules), etc. "Modified forms" include modified forms of the nucleic acid sequence itself in which one or more nucleic acids have been "deleted," "substituted," "added," or "inserted" to the extent that the function of the gene is not impaired, as well as those that have been subjected to known modifications used in nucleic acid medicines, etc., such as "methylation," "phosphorylation," "amino group modification," and others.
[0027] Specific examples of "viruses" include those listed in Table 1 below.
[0028] [Table 1] (What are microorganisms?) Examples of "microorganisms" that are "targets for removal" by the composition of the present invention include the following pathogenic microorganisms, or mutants or artificial variants thereof, etc., as targets against which the composition of the present invention can be effectively effective, but are not limited to these.
[0029] (eukaryotes)
[0030] fungi: Trichophyton (athlete's foot fungus), Candida, Cryptococcus, Coccidioides immitis, etc.
[0031] Bacteria: In addition to mycoplasmas such as Mycoplasma pneumoniae, various pathogenic bacteria are included.
[0032] Protozoa: Malaria parasites, Entamoeba histolytica, Trichomonas vaginalis, Pneumocystis carinii pneumoniae, Echinococcus, etc., or eggs of these protozoa, etc.
[0033] (prokaryotes)
[0034] Spirochetes: Treponema pallidum, Borrelia (Lyme disease, relapsing fever), Leptospira (Weil's disease), etc.
[0035] Rickettsia: A round, animal-derived microorganism that causes typhus, scrub typhus, Q fever (burnetii), Japanese spotted fever, etc.
[0036] chlamydia: intracellular parasite that causes psittacosis, trachoma, lymphogranuloma venereum, and chlamydial sexually transmitted diseases
[0037] In the present invention, hereinafter, "virus and / or microorganism" may be simply referred to as "virus, etc."
[0038] (What is removal?) In the present invention, "removal" means killing, inactivating, inactivating, or inhibiting the growth of the harmful substance, such as a virus, that is the target of removal, as well as physically destroying or removing it from the target site, and also includes disinfection, rendering it harmless, neutralizing, sterilization, disinfection, decontamination, etc. Growth inhibition refers to (at least temporarily) suppressing the proliferation of viruses and the like by suppressing the growth itself or the growth rate, so to speak, by putting the virus into a "dormant" or "hibernating" state. The term "inactivated" refers to a state in which, although not completely killed, the biological activity and other functions are almost completely lost. Inactivation refers to a state in which physiological activity or other actions are temporarily suppressed for some reason.
[0039] Furthermore, when a group of bubbles smaller than nano-size (less than 1 μm) come into contact with viruses that are several nanometers to several hundred nanometers in size, they generate extremely large amounts of energy, for example, 3000 K (Kelvin) or more (equivalent to approximately 2,300 degrees Celsius), through crushing, etc., and therefore it is believed that the "composition for removing harmful substances" of the present invention can kill or at least inactivate most "viruses." Furthermore, since bubble collapse is likely to occur when encountering an object of similar size, in the case of microorganisms larger than bubbles, including bacteria that are approximately 1 to 5 μm in size, an inactivation or growth inhibition effect, particularly an inhibition of the growth rate, can be expected by preventing explosive growth associated with aggregation of microorganisms, rather than killing or deactivating them.
[0040] <<Bubbles (I) used in the present invention having an average bubble diameter of nano-sized or less>> As the "gas component" in the group of bubbles (I) having an average bubble diameter of nano-sized or less used in the present invention, for example, the following are preferable, but not necessarily limited thereto.
[0041] (Type of gas in bubbles) The "gas component" in the bubbles is preferably one or more of the following:
[0042] (i) Atmosphere (ii) Hydrogen (iii) Nitrogen (iv) Ozone (v) Oxygen (vi) Carbon dioxide (vii) Argon
[0043] When the air (i) is used alone, it is practical and preferable since there is no need to prepare special "gaseous components" such as those (ii) to (vii).
[0044] Furthermore, when "air" or "a mixed gas of two or more kinds" is introduced into the solvent (II), it is not easy to accurately measure the "entrapment ratio of each gas component" in the "bubbles (I) generated in the solvent (II)." This is because, in the process of generating bubbles (I) in the solvent (II), the "amount" and "speed" at which each "gaseous component" can dissolve in the solvent (II) differs, and it is not easy to accurately determine the "type" and "ratio" of the "gaseous components" enclosed in the generated bubbles (I). However, for example, when a single-type “gas component (let’s call it X)” is used, the “encapsulation ratio” of “gas component (X)” in “bubbles (I) generated in solvent (II)” should be higher than when a mixed gas such as air is used, and it is believed that this will enable the above-mentioned characteristics of “gas component (X)” (for example, ability to remove viruses, etc.) to be more effectively utilized.
[0045] Therefore, it may be preferable to enclose, as the "gaseous component" in the bubbles, a "gas that has an effect of removing harmful substances (such as viruses) (see (III) below)" such as "ozone" in place of the atmosphere or to replace part of the atmosphere.
[0046] (III) Gases that have the effect of removing harmful substances
[0047] However, the "composition for removing harmful substances" of the present invention does not have to enclose such gaseous components, which have high disinfecting power but may also have adverse effects on the human body depending on the concentration and application method, and can effectively remove viruses and the like using only the energy generated when phenomena such as the collapse of air bubbles occur.Therefore, there is no need to prepare any special "gaseous components"; "air" is sufficient.
[0048] Incidentally, even when "air" is used as the gas component, there is a possibility that (III) and the like may be enclosed in the bubbles. However, at the same ratio as that contained in air, it is naturally considered that this is almost harmless to the human body.
[0049] For example, in order to increase the ratio of a specific "gas component (X)" in the bubbles compared to the atmosphere, methods include using "gas component (X)" alone, as well as using both the atmosphere and "gas component (X)."
[0050] In this case, the atmosphere and the "gas component (X)" alone may be enclosed at the same time, but other methods include gradually increasing the concentration of the "gas component (X)" enclosed together with the atmosphere, or using only the atmosphere at the beginning and enclosing the "gas component (X)" in a later stage. By using these methods, it is believed that the loss of the "gas component (X)" due to dissolution in the solvent, etc., can be minimized and a larger amount of the "gas component (X)" can be enclosed in the bubbles.
[0051] The ratio of air and "gaseous component (X)" when used simultaneously is not particularly limited, but in order to encapsulate as much "gaseous component (X)" as possible, it is considered preferable that the amount of "gaseous component (X)" used in the encapsulation operation is, for example, 10 times or more the amount of "(i) air" used, and more preferably 100 times or more the amount of "(i) air" used.
[0052] During this sealing process, it is considered that some of the "gaseous component (X)" will dissolve in the solvent (II). If the dissolved "gaseous component (X)" itself has a removing effect against viruses, etc., the solvent itself can be expected to have a certain degree of decontamination effect, similar to the conventional so-called ozone water.
[0053] Therefore, in addition to the natural dissolution when enclosed in the bubbles, it may be preferable to deliberately dissolve the above-mentioned "(III) gas having the effect of removing harmful substances" separately in the solvent (II), since this can enhance the harmful substance removing ability of the composition of the present invention through a synergistic effect with the energy generated when phenomena such as the collapse of the bubbles occur.
[0054] (bubble size) The size of the bubbles used in the "composition" of the present invention must be such that the average bubble diameter is nano-sized or less, but the specific size can be changed flexibly depending on the circumstances.
[0055] When the "target for removal" is a "virus," it is preferable that the size of the bubbles be close to or smaller than the size of the virus itself (generally 10 to 100 nm) in order to ensure that the energy of 3000 K (Kelvin) or more (equivalent to approximately 2,300 degrees Celsius) generated when the bubbles get as close as possible to the virus and phenomena such as the collapse of the bubbles occurs is sufficient to denature and destroy lipid components such as the envelope located on the outside of the virus and capsid proteins.
[0056] Furthermore, when a "gas that in itself has the ability to remove harmful substances such as viruses and microorganisms" such as ozone is used as the gas contained in the bubbles of nanobubbles, the smaller the bubble size is made, the greater the amount of bubbles, etc. that inevitably dissolve in the solvent as the bubbles are produced. This makes it possible to endow the solvent itself with removal capabilities, which is preferable because it synergistically enhances the removal capabilities of the composition as a whole.
[0057] Therefore, in order to exert removal performance against most viruses and the like, the smaller the bubbles, the better. Furthermore, the smaller the bubbles, the greater the number of bubbles per unit volume of the composition, and the greater the total amount of energy generated by bubble collapse in the composition. However, when it is desired to remove a specific target particularly thoroughly, it is preferable to have a higher proportion of bubbles of the same size as the target (e.g., virus), as this is thought to make it easier for bubble collapse to occur.
[0058] When the "removal target" is a fungus, the size of the air bubbles needs to be smaller than the size of the fungus itself (generally a few μm).
[0059] (Ratio of bubbles smaller than nano size to all bubbles) The proportion of "sub-nanosized bubbles" among all the bubbles in the "composition" of the present invention does not necessarily have to be 100%.
[0060] However, the reason why the "composition of the present invention" has a higher removal effect than conventional "various disinfectants using nanobubbles" is due to the explosive energy generated when high-density nanobubbles are crushed, etc., and therefore the more "bubbles smaller than nano size" in the composition, the better, and in particular, the higher the ratio of bubbles having a size equivalent to that of the viruses, etc., to be removed, the better.
[0061] Furthermore, since the presence of many bubbles larger than nanosize may cause denaturation of the composition due to the collapse of the large bubbles, it is desirable for the proportion of "bubbles smaller than nanosize" to be as high as possible, for example, preferably 50% or more, more preferably 60% or more, even more preferably 70% or more, particularly preferably 80% or more, and most preferably 90% or more.
[0062] Moreover, the size of the bubbles is not necessarily uniform, and generally has a certain degree of bubble size distribution.
[0063] Therefore, as a specific guideline, if the "average diameter" of the bubbles (average bubble diameter) is nano-sized or smaller (less than 1 μm), it is believed that a large number of small bubbles are also included.
[0064] (Number of bubbles in the composition) As described above, a larger number of bubbles in the "composition" of the present invention is desirable because the total amount of heat generated by the collapse of the bubbles increases. The specific number varies depending on the type and concentration of the object to be removed (number of viruses, etc.), and cannot be generalized, but it has been confirmed that several thousand to several hundred million bubbles / ml, which is generally generated when using a known manufacturing device capable of manufacturing "(I) a group of bubbles having an average bubble diameter of nano-size or less," is sufficient. However, it is considered that tens of millions to several hundred million bubbles / ml is more preferable.
[0065] More specifically, for example, the concentration of (I) is preferably 50 million / ml or more, more preferably 80 million / ml or more, even more preferably 100 million / ml or more, and particularly preferably 200 million / ml or more.
[0066] As a method for measuring the average bubble diameter of a bubble group, there is a method using the Coulter principle described below, known as the Electrical Sensing Zone Method. Specifically, there is a method using "Multisizer3", "Multisizer4", "Multisizer4e" or the like manufactured by Beckman Coulter, Inc.
[0067] The Coulter principle is a principle in which a certain amount of electrolyte is flowed inside a tube (manometer) with fine conductive holes (apertures), electrodes are placed inside and outside the manometer, and a DC voltage (positive to the internal electrode, negative to the external electrode) is applied, and when a particle (bubble, etc.) passes through the detection zone (aperture sensitive area), the electrical resistance between the two electrodes changes in proportion to the size (volume) of the particle. By detecting and amplifying this change in electrical resistance, the number and volume of particles can be measured simultaneously, and the average bubble diameter can be calculated.
[0068] <<Solvent (II) Used in the Present Invention>> The solvent (II) used in the present invention is not particularly limited, and may be purified water, physiological saline, mineral water, soft drinks, or the like.
[0069] When using equipment made of stainless steel or the like as a device for generating bubbles of (I) in the solvent (II), purified water, mineral water, or the like may be preferable from the viewpoint of preventing the equipment from rusting.
[0070] (Method of generating bubbles) Examples of the method for "generating bubbles (I) in a solvent (II)" include the following methods and combinations thereof, but are not limited to these.
[0071] Gas-liquid mixing shear method: This method involves swirling gas together with liquid at high speed.
[0072] Ultrasonic method: This method involves adding shock waves or cavitation to the liquid to further collapse any bubbles that have formed.
[0073] Pressurized dissolution method: This method creates bubbles by applying pressure to gas and liquid and releasing it all at once.
[0074] Micropore method: This is a method in which gas is supplied under pressure using an orifice or the like.
[0075] Electrolysis method: This method involves generating gas from a thin wire immersed in an aqueous solution.
[0076] Among the above, the "gas-liquid mixed shear method" is preferable because it is possible to generate stable bubbles of nanometer size or smaller by further shearing the microbubbles.
[0077] Specifically, nanobubbles can be generated by using commercially available devices such as those described in 1) and 2) below in combination. 1) Generation of bubbles with a diameter of 1 micrometer or less using Kyowa Kisei's micro-nano bubble generator "Vavitas (registered trademark) HYK-25" (rotational shear method) 2) Micro-nano bubbles produced by Ahachi Co., Ltd.'s "νG7 (registered trademark)" are converted into nano bubbles (stainless steel filter)
[0078] The use of the "ultra-fine bubble generator" developed by the present inventor and described in the following patent application is particularly preferred because it can efficiently generate nanobubble water with bubbles having a particle size of less than 1 μm, for example an average bubble size on the order of several nm to several hundred nm, and a high concentration (number of bubbles).
[0079] Patent application 2020-57176 (Inventor's patent application 1)
[0080] Other Ingredients Furthermore, the "harmful substance removal composition" of the present invention may contain various additives such as other known "substances having the effect of removing viruses, microorganisms, and other harmful substances (regardless of whether they are natural or artificial, organic or inorganic, etc.)" such as alcohol and hypochlorous acid, as well as dyes, pigments, disinfectants, antibacterial agents, pH adjusters, stabilizers, preservatives, antioxidants, thickeners, viscosity adjusters, etc., within the scope that does not impair the object of the present invention.
[0081] <<Production method of the "composition for removing harmful substances" of the present invention>> The composition of the present invention comprises The air bubbles of (I) are mixed in the solvent of (II) containing various additives as required by the above method. How to generate a swarm or After the bubbles of (I) are generated in the solvent of (II) by the above-mentioned method, various kinds of A method of incorporating additives such as It can be manufactured by the above.
[0082] <<Form of the "Composition for Removing Harmful Substances" of the Present Invention>> The "composition for removing harmful substances" of the present invention is not particularly limited in its form, and can take any known composition form, so long as it does not cause the collapse of the "group of bubbles (I) having an average bubble diameter of nanometers or less" in the composition, but is preferably in the form of, for example, a liquid or gel.
[0083] When the liquid is used with, for example, a sprinkler or sprayer, it is preferable that the liquid has a low viscosity so that it can be dispersed or sprayed. Other examples include disinfectant sprays, disinfectant gels, and hand soaps.
[0084] Representative products of "oral compositions" for administration via the oral cavity include therapeutic compositions such as "pharmaceuticals" and "quasi-drugs", "food and beverage products", and "nutritional supplements" for humans or non-human animals. Examples of "ophthalmic compositions" include "eye drops." Examples of "otorhinological compositions" include "nasal drops". Examples of "compositions for transdermal administration" include "patches" such as "cataplasms" and "topical ointments" such as "ointments" and "sprays."
[0085] [Method for removing hazardous substances according to the present invention] The method for removing harmful substances of the present invention can be carried out by using the above-mentioned composition of the present invention.
[0086] Specifically, for example, the liquid composition of the present invention can be dispersed or sprayed with a sprinkler or sprayer into a space from which viruses and the like are to be removed, thereby removing the viruses and the like.
[0087] In addition, as mentioned above, it can be used in the form of disinfectant spray, disinfectant gel, and hand soap to remove viruses and other microorganisms.
[0088] [Method for confirming the effectiveness of virus removal (method for measuring remaining viruses)] Examples of methods include, but are not limited to, a method using a known "Next Generation Sequencer (NGS)" as described below, and measuring known genes specific to each virus as indicators.
[0089] (Next Generation Sequencing (NGS)) "Next-generation sequencers" were developed in the United States around 2000 and are instruments that can read out the base sequences of a much larger number of DNA fragments in parallel than conventional DNA sequencers. They were pioneered by American companies such as Illumina.
[0090] In the present invention, next-generation sequencers manufactured by Illumina Inc. can be used, for example, DNA sequencers such as the "MiSeq series," "NextSeq series," and "HiSeq series." The principles and methods of use thereof are disclosed below.
[0091] https: / / jp.illumina.com / landing / s / metagenome.html
[0092] When the measurement target is RNA, it can be converted into the corresponding cDNA by reverse transcriptase and then measured.
[0093] In addition to the above, the following known TCID50 test can also be used as a simple test method.
[0094] (TCID50 test) The TCID50 test (50% Tissue Culture Infectious Dose) is a method that utilizes the phenomenon in which cells change shape (cytopathic) when infected with a virus.
[0095] The concentration of a virus sample capable of denatureing 50% of host cells can be measured as an index of the infectivity of the virus sample.
[0096] In other words, the virus removal ability of the compositions can be comparatively evaluated by comparing the "limit dilution ratio" at which a virus sample treated with the "composition for removing harmful substances" of the present invention shows 50% toxicity to host cells. EXAMPLES
[0097] [Examples 1 to 3: Compositions for removing harmful substances] Materials and methods
[0098] (Production of "Nanobubble Water") Using the "ultra-fine bubble generator" described in the inventor's patent application 1 mentioned above, nanobubble water (stock solution) of samples A, B, and C (Examples 1, 2, and 3) was produced. Incidentally, "ultra-fine bubbles" refer to minute bubbles below nano size (less than 1 μm).
[0099] All of Samples A to C were produced using the ultra-fine bubble generator 10A described as the second embodiment in the present inventor's patent application 1. The carrier water used was RO water (reverse osmosis water) containing minerals (cations) as solutes, and hydrogen was used as the replacement gas.
[0100] The samples were manufactured using the same equipment but at different times. Sample A was the first sample measured after the prototype was manufactured, and is approximately 9 years (approximately 9 years and 3 months) old based on the measurement date. Sample B was collected approximately one year prior to the measurement date. Sample C was collected 9 days before the measurement date. The tap water was collected and measured on the day of measurement as a reference.
[0101] It goes without saying that tap water does not contain any ultrafine bubbles, but when measured with this measuring device, the number of particles mixed in the tap water is measured. Samples A, B, and C were diluted 4000-fold with degassed water (a sample approximately 400-fold diluted was further diluted 10-fold for measurement) (diluted Samples A, B, and C).
[0102] This is because the ultra-fine bubble water (samples A, B, and C) generated by the device of this embodiment contained such a large amount of bubbles that it could not be measured unless it was diluted 4000 times. Note that degassed water obtained by applying negative pressure to running tap water and storing it in a flask was used for dilution.
[0103] Using a Beckman Coulter "Multisizer4e," the "original nanobubble water solution (samples A, B, and C)" prepared above was diluted 4,000 times for the convenience of bubble diameter measurement, and the size, number (concentration), etc. of the bubbles in the diluted solutions (samples A, B, and C) were measured.
[0104] The results are shown in Figure 1, and the average bubble diameter and bubble concentration are shown below.
[0105] Sample A: Average bubble diameter 391 nm - bubble concentration 58026 pieces / ml Sample B: Average bubble diameter 490 nm - bubble concentration 412198 pieces / ml Sample C: Average bubble diameter 383 nm - bubble concentration 168464 pieces / ml
[0106] Therefore, the bubble concentrations of the "nanobubble water (samples A, B, C)" (undiluted stock solution) used in the present invention are considered to be as follows:
[0107] Sample A: 58026 x 4000 = approx. 230 million particles / ml Sample B: 412198 x 4000 = approx. 1.65 billion particles / ml Sample C: 168464 x 4000 = approx. 670 million particles / ml
[0108] [Examples 4-5: Composition for removing harmful substances] Example 4 (hydrogen nanobubble water) was prepared as a "composition for removing harmful substances" in the same manner as in Examples 1 to 3, except that hydrogen alone was used as the gas component to be enclosed. Similarly, a "composition for removing harmful substances" was produced in the same manner as in Examples 1 to 3, except that ozone alone was used as the gas component to be enclosed, and this was designated as Example 5 (ozone nanobubble water).
[0109] [Comparative Example 1: Composition for removing harmful substances] For comparison, ultrapure water was used as the “composition for removing hazardous substances” in Comparative Example 1.
[0110] [Test Example 1 (Virus Removal Test)] The effectiveness of the following "composition for removing harmful substances" in removing influenza viruses was confirmed.
[0111] Test Subjects: Example 3 "Composition for removing harmful substances" (partially hydrogen-substituted atmospheric nanobubble water) Example 4 "Composition for removing harmful substances" (hydrogen nanobubble water) Example 5 "Composition for removing harmful substances" (ozone nanobubble water) Comparative Example 1 "Composition for removing harmful substances" (Ultrapure water)
[0112] Target for removal; Influenza virus (single-stranded RNA virus)
[0113] Test Method: The TCID50 test described above was employed.
[0114] Test results: <The ratio of the limit dilution rate at which 50% of the host cells can be denatured> 100-fold dilution (treatment of Example 3): 1000-fold dilution (treatment of Comparative Example 1) 10-fold dilution (treatment of Example 4 or 5): 1000-fold dilution (treatment of Comparative Example 1)
[0115] In other words In the case of the virus sample treated with the composition of Example 3, the limit value of the dilution ratio at which the virus can be inactivated is one order of magnitude lower than that of the sample treated with the composition of Comparative Example 1. In the case of the virus samples treated with the compositions of Examples 4 and 5, the results showed that the limit value of the dilution ratio at which the virus could be inactivated was two or more orders of magnitude lower than that of the samples treated with the composition of Comparative Example 1.
[0116] Consideration: This is believed to be because the influenza virus comes into contact with a large number of nanobubbles in the composition of the present invention, causing the bubbles to collapse, etc., resulting in the high energy generated during the process damaging the influenza virus, which in turn deteriorates the cytopathic ability (infectivity) of the virus sample.
[0117] [Test Example 2 (Bacteria Removal Test 1)] The effectiveness of the following "harmful substance removing composition" in removing general viable bacteria in living spaces was confirmed.
[0118] Test Subjects: Example 3 "Composition for removing harmful substances" (partially hydrogen-substituted atmospheric nanobubble water) Example 5 "Composition for removing harmful substances" (ozone nanobubble water)
[0119] Remove: Bacteria that grow in living spaces (especially spaces that have not been disinfected)
[0120] Test Method: (Sample collection) On the same desk in the living space, the following three test circles (approximately 8 cm radius) were drawn with an interval of about 50 cm, and 1 ml of the following nanobubble water (NB water) was sprayed on the two circles other than the blank, and for each of the three circles, 10 places within the circle were immediately wiped randomly with a sterile cotton ball to prepare samples. The 10 places were wiped evenly by rotating one sterile cotton ball.
[0121] H2-NB water circle: "Composition for removing harmful substances" of Example 3 (partially hydrogen-substituted atmospheric nanobubble water) O3-NB water circle: "Composition for removing harmful substances" of Example 5 (ozone nanobubble water) Blank - Circle: Living space as is (no spray)
[0122] (Bacterial culture) The microorganisms attached to the sterile cotton ball were thoroughly suspended in the suspension liquid, and 1 ml of each suspension liquid was used as an evaluation sample. 1 μl of each evaluation sample was taken using a quantitative platinum loop, smeared on an agar plate, and cultured for 2 days in an incubator at 35°C according to the standard method for measuring general viable bacterial counts.
[0123] (General viable bacteria count) After culturing for two days, the number of colonies on the agar plate was visually counted and defined as the general viable cell count (number of colonies after two days) per 1 μl of each evaluation sample.
[0124] Incidentally, the term "general viable bacteria" refers to so-called "miscellaneous bacteria," that is, indicator bacteria that show the degree of contamination under the Food Sanitation Law.
[0125] Test results: "General viable bacteria count" H2-NB water circle (Example 3): less than 10 colonies / 1 μl evaluation sample: clean O3-NB water circle (Example 5): Number of colonies less than 10 / 1 μl of evaluation sample: Clean Blank - Circle: 20 colonies / 1 μl of evaluation sample: Moderate contamination (*All evaluation samples, both in the working examples and blanks, were negative for Escherichia coli and Staphylococcus aureus.)
[0126] In other words, the samples treated with the "Composition for Removing Harmful Substances" of the embodiment had a clearly lower number of general live bacteria compared to the blank, and it was found that the moderately contaminated state under the Food Sanitation Act had become a clean level.
[0127] Consideration: This shows that the harmful substance removing agent of the present invention is effective in inhibiting the proliferation of general live bacteria (unwanted bacteria).
[0128] [Test Example 3 (Bacteria Removal Test 2)] For the "harmful substance removal composition" described below, the "foam concentration" that can sufficiently exert the "growth inhibitory effect" on intestinal bacteria was confirmed.
[0129] The enterobacteria sample used here is not necessarily a "harmful substance whose proliferation should be inhibited," but it was selected here as a representative sample with a large number of bacteria (high concentration) in order to confirm the "bubble (nanobubble) concentration" that can inhibit bacterial proliferation.
[0130] Test Subjects: O3-NB-1) "Composition for removing harmful substances" of Example 5 (ozone nanobubble water, undiluted solution) O3-NB-2) 20-fold dilution of Example 5 O3-NB-3) 100-fold dilution of Example 5 O3-NB-4) 1000-fold dilution of Example 5
[0131] For the dilution, "distilled water for injection" was used.
[0132] Target for removal: (intestinal bacteria) 100 g of human feces was immersed in 250 ml of hydrogen partial replacement atmospheric nanobubble water and gently stirred to allow the feces to dissolve naturally, obtaining a solution (A). Next, this solution (A) was filtered multiple times using sterilized gauze until no unwanted matter such as food residue could be observed under an optical microscope (low magnification), to obtain a filtrate (B). The filtrate (B) was diluted 1000-fold with distilled water for injection to prepare the “intestinal bacteria sample stock solution” (C) to be removed.
[0133] The sterilized gauze used had pores large enough to allow the "intestinal bacteria" and "nanobubbles" to pass through.
[0134] In addition, the reason why "partially hydrogen-substituted atmospheric nanobubble water" was used when dissolving the feces was to ensure the long-term preservation of the "intestinal bacteria sample stock solution" (C) under sealed storage. In preparing the "evaluation sample" described below, the above-mentioned test subject (ozone nanobubble water) is added again to the "intestinal bacteria sample stock solution" (C). However, the "hydrogen partial replacement atmospheric nanobubble water" used to ensure long-term storage is not considered to have a significant effect on the comparison of the inhibitory effect on the proliferation rate of intestinal bacteria by "various concentrations of ozone nanobubble water" in the culture test described below. In the culture test described below, the samples are opened from a sealed storage state and cultured, so nanobubble water is thought to be necessary again to suppress the growth rate of the "intestinal bacteria that are likely to become active again."
[0135] Test Method: (Creating an evaluation sample) To 10 μl of the above-mentioned enterobacteria sample stock solution (C), 9990 μl of each of the nanobubble waters to be tested (stock solution and each diluted solution of Example 5) was added (1000-fold dilution) to obtain evaluation samples-1) to 4).
[0136] (Bacterial culture) 1 μl of each evaluation sample was taken using a quantitative platinum loop, smeared on an agar plate, and cultured for 2 days in an incubator at 35°C according to the standard method for measuring general viable bacterial counts.
[0137] (Counting the number of intestinal bacteria) After culturing for two days, the number of colonies on the agar plate was visually counted and recorded as the general viable bacterial count (number of colonies after two days) per 1 μl of each evaluation sample.
[0138] Test results: Evaluation sample-1): Number of enterobacteria colonies: 20 / 1μl Evaluation sample-2): Number of enterobacteria colonies: 40 / 1μl Evaluation sample-3): Number of enterobacteria colonies: 20 / 1μl Evaluation sample-4): Number of enterobacteria colonies: 70 / 1μl
[0139] As described above, it was found that the proliferation of intestinal bacteria could be inhibited to some extent even when the "harmful substance removal composition" of Example 5 (ozone nanobubble water, undiluted solution) was diluted 1000 times.
[0140] Consideration: The nanobubble water of Example 5 was produced within 9 days, and therefore has approximately the same number of bubbles as Example 3 (Sample C: bubble concentration: approximately 670 million bubbles / ml). In other words, the above results mean that nanobubble water with a bubble concentration of 670,000 bubbles / ml or more can fully exert the "growth inhibitory effect" on intestinal bacteria. [Industrial Applicability]
[0141] The composition for removing harmful substances of the present invention is not only capable of effectively removing harmful substances such as various viruses and microorganisms, but is also thought to be less likely to develop resistance compared to the use of drugs, etc., and is therefore thought to be extremely beneficial to public health.
Claims
1. A method for producing a composition for removing harmful substances, which does not contain a bactericidal component, characterized in that it contains the following (I) and (II), wherein the harmful substance is at least one selected from viruses, microorganisms, and toxins. (I) A group of bubbles having an average bubble diameter of nano-sized or less (less than 1 μm) (excluding those containing ozone as a gas component in the bubbles), which is obtained by a bubble generating step of generating bubbles by a rotational shear method, and a nanobubble generating step of converting the bubbles generated by the bubble generating step into nanobubbles using a filter. (II) Solvent
2. 2. The method for producing the composition according to claim 1, wherein the gas component in the bubbles is one or more of the following: (i) Atmosphere (ii) Hydrogen (iii) Nitrogen (iv) oxygen (v) Carbon dioxide (vi) Argon
3. 3. The method for producing a composition according to claim 1 or 2, wherein the concentration of (I) is 50 million particles / ml or more.
4. 4. A method for producing a composition according to claim 1, wherein the concentration of (I) is 80 million particles / ml or more.
5. The method for producing a composition according to any one of claims 1 to 4, wherein the harmful substance is at least one selected from the group consisting of viruses and / or microorganisms.
6. A method for removing harmful substances by using a composition produced by the method for producing a composition according to any one of claims 1 to 5.
Citation Information
Patent Citations
Raw milk processing method
CN107912527A
Method for annihilating escherichia coli or virus, or inhibiting proliferation thereof
JP2011115326A
Fine air bubble generator
JP2013215634A
Electrolytic water micro nano-bubble generator
JP2015098014A
Fine bubble liquid manufacturing device
JP2017217585A
